University of Calgary - Advanced Contract Award Notice / Notice of Proposed Procurement - Custom Plex Assay Service

Eve Technologies will be performing biomarker assays on breast cancer patient samples for the Alberta Moving Beyond Breast Cancer (AMBER) Research Study. Eve Technologies is equipped with a comprehensive suite of Luminex analyzers, their skilled technicians can perform multiple assays simultaneously from a single sample aliquot. This capability not only significantly improves turnaround times but also minimizes freeze/thaw cycles on valuable samples, ensuring both efficiency and integrity. In order to meet funder deadlines for the grant and due to the nature of the project, using a local vendor will shorten the lead time and avoid customs delays/ shipping delays or international transportation interruption issues. It is UCalgary’s understanding that Eve Technologies is the only CLIA-regulated laboratory in Canada.